Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and Female patients with ADHD ages 18-54.~* Patient must have ADHD symptoms that cause problem(s) in the home setting.~Exclusion Criteria:~* Have failed to respond to an adequate trial of treatment with an ADHD stimulant medication, bupropion, or other nonstimulant medication.~* Are taking any antipsychotic medication or mood stabilizers within 8 weeks of Visit 1

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 54 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).